A phase II trial of bemdaneprocel
Latest Information Update: 04 Sep 2023
At a glance
- Drugs Bemdaneprocel (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
Most Recent Events
- 04 Sep 2023 New trial record
- 28 Aug 2023 According to a BlueRock Therapeutics media release, the company expected to begin enrolling participants in H1 (first half) 2024.